JOSHUA HARRIS: Open Payments
NPI 1083087597 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 98 payments from 25 companies in 2025. Trend: 2023 $1,403 · 2024 $1,578 · 2025 $1,847
Food & beverage: $1,847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $500 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $238 |
| PFIZER INC. | 13 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $158 |
| Novo Nordisk Inc | 7 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Lilly USA, LLC | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
Products named: CAPLYTA, QULIPTA, UBRELVY, Kerendia, JARDIANCE, TRINTELLIX, NURTEC ODT, VRAYLAR.
Industry payments across VA — which companies pay providers there.
